Nutrition facts in multiple sclerosis

ASN Neuro

Volumn 7, Issue 1, 2015, Pages 1-20

  Riccio, Paolo ^a   Rossano, Rocco ^a  

^a UNIVERSITY OF BASILICATA   (Italy)

Author keywords

Complementary alternative medicine; Gut microbiota; Inflammation; Lifestyle; Multiple sclerosis; Nutrition

Indexed keywords

CAROTENOID; ESSENTIAL FATTY ACID; FISH OIL; MILK FAT; OMEGA 3 FATTY ACID; POLYPHENOL; POLYUNSATURATED FATTY ACID; RETINOL; TRANS FATTY ACID; VITAMIN D;

ALCOHOL CONSUMPTION; ARTICLE; CALORIC RESTRICTION; CELL METABOLISM; DIETARY FIBER; DOWN REGULATION; ENTERITIS; EXERCISE; FEEDING BEHAVIOR; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INTERVENTION STUDY; INTESTINE FLORA; LIFESTYLE; MEDITERRANEAN DIET; MULTIPLE SCLEROSIS; NUTRITION; QUALITY OF LIFE; SALT INTAKE; SUGAR INTAKE; UPREGULATION; WESTERN DIET; ANIMAL; DIET THERAPY; DIETARY SUPPLEMENT; GASTROINTESTINAL TRACT; MICROBIOLOGY; MICROFLORA; PSYCHOLOGY; RAT;

ANIMALS; DIETARY SUPPLEMENTS; GASTROINTESTINAL TRACT; HUMANS; LIFE STYLE; MICROBIOTA; MULTIPLE SCLEROSIS; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; RATS;

EID: 84925842660     PISSN: None     EISSN: 17590914     Source Type: Journal    
DOI: 10.1177/1759091414568185     Document Type: Article

References (167)

1. Aguiar, A. S. Jr., Stragier, E., da Luz Scheffer, D., Remor, A. P., Oliveira, P. A., Prediger, R. D., Lanfumey, L. (2014). Effects of exercise on mitochondrial function, neuroplasticity and anxio-depressive behavior of mice. Neuroscience, 271, 56–63.
2. Aharoni, R. (2013). The mechanism of action of glatiramer acetate in multiple sclerosis and beyond. Autoimmunity Reviews, 12, 543–553.
3. Al-Daghri, N. M., Guerini, F. R., Al-Attas, O. S., Alokail, M. S., Alkharfy, K. M., Hossam, M., Clerici, M. (2014). Vitamin D receptor gene polymorphisms are associated with obesity and inflammosome activity. PLoS ONE, 9(7): e102141 doi:10.1371/journal.pone.0102141.
4. An, B. S., Tavera-Mendoza, L. E., Dimitrov, V., Wang, X., Calderon, M. R., Wang, H. J., White, J. H. (2010). Stimulation of Sirt1-regulated FoxO protein function by the ligand-bound vitamin D receptor. Molecular and Cellular Biology, 30, 4890–4900.
5. Ascherio, A. (2013). Environmental factors in multiple sclerosis. Expert Review of Neurotherapeutics, 13(12 Suppl): 3–9.
6. Ascherio, A., Munger, K. L., & Lünemann, J. D. (2012). The initiation and prevention of multiple sclerosis. Nature Reviews Neurology, 8, 602–612.
7. Ascherio, A., Munger, K. L., White, R., Köchert, K., Simon, K. C., Polman, C. H., Pohl, C. (2014). Vitamin D as an early predictor of multiple sclerosis activity and progression. JAMA Neurology, 71, 306–314.
8. Bavarsad Shahripour, R., Harrigan, M. R., & Alexandrov, A. V. (2014). N-acetylcysteine (NAC) in neurological disorders: Mechanisms of action and therapeutic opportunities. Brain and Behavior, 4, 108–122.
9. Berer, K., Mues, M., Koutrolos, M., Rasbi, Z. A., Boziki, M., Johner, C., Krishnamoorthy, G. (2011). Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature, 479, 538–541.
10. Bernardo, A., Bianchi, D., Magnaghi, V., & Minghetti, L. (2009). Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells. Journal of Neuropathology and Experimental Neurology, 68, 797–808.
11. Bhardwaj, S., Passi, S. J., & Misra, A. (2011). Overview of trans fatty acids: Biochemistry and health effects. Diabetes and Metabolic Syndrome, 5, 161–164.
12. Boosalis, M. G. (2008). The role of selenium in chronic disease. Nutrition in Clinical Practice, 23, 152–160.
13. Boots, A. W., Haenen, G. R., & Bast, A. (2008). Health effects of quercetin: From antioxidant to nutraceutical. European Journal of Pharmacology, 585, 325–337.
14. Bouillon, R., Carmeliet, G., Lieben, L., Watanabe, M., Perino, A., Auwerx, J., Verstuyf, A. (2014). Vitamin D and energy homeostasis: Of mice and men. Nature Reviews Endocrinology, 10, 79–87.
15. Bravo, L. (1998). Polyphenols: Chemistry, dietary sources, metabolism and nutritional significance. Nutrition Reviews, 56, 317–333.
16. Brown, K., DeCoffe, D., Molcan, E., & Gibson, D. L. (2012). Dietinduced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients, 4, 1095–1119.
17. Burns, K. A., & Vanden Heuvel, J. P. (2007). Modulation of PPAR activity via phosphorylation. Biochimica et Biophysica Acta, 1771, 952–960.
18. Caito, S., Rajendrasozhan, S., Cook, S., Chung, S., Yao, H., Friedman, A. E., Rahman, I. (2010). SIRT1 is a redoxsensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress. FASEB Journal, 24, 3145–3159.
19. Calder, P. C. (2006). n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. American Journal of Clinical Nutrition, 83, 1505S–1519S
20. Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., Burcelin, R. (2008). Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes, 57, 1470–1481.
21. Cani, P. D., & Delzenne, N. M. (2009). The role of the gut microbiota in energy metabolism and metabolic disease. Current Pharmaceutical Design, 15, 1546–1558.
22. Cantorna, M. T. (2012). Vitamin D, multiple sclerosis and inflammatory bowel disease. Archives of Biochemistry and Biophysics, 523, 103–106.
23. Castro, S. B., Junior, C. O., Alves, C. C., Dias, A. T., Alves, L. L., Mazzoccoli, L., El-Rayes, B. F. (2013). Pleiotropic effects of genistein in metabolic, inflammatory, and malignant diseases. Nutrition Reviews, 71, 562–572.
24. Chassaing, B., & Gewirtz, A. T. (2014). Gut microbiota, low-grade inflammation, and metabolic syndrome. Toxicologic Pathology, 42, 49–53.
25. Cheng, G., Zhang, X., Gao, D., Jiang, X., & Dong, W. (2009). Resveratrol inhibits MMP-9 expression by up-regulating PPAR alpha expression in an oxygen glucose deprivationexposed neuron model. Neuroscience Letters, 451, 105–108.
26. Chiellini, G., Rapposelli, S., Zhu, J., Massarelli, I., Saraceno, M., Bianucci, A. M., DeLuca, H. F. (2012). Synthesis and biological activities of vitamin D-like inhibitors of CYP24 hydroxylase. Steroids, 77, 212–223.
27. Coluccia, A., Borracci, P., Renna, G., Giustino, A., Latronico, T., Riccio, P., Carratú, M. R. (2009). Developmental omega-3 supplementation improves motor skills in juvenile-adult rats. International Journal of Developmental Neuroscience, 27, 599–605.
28. Constantinescu, C. S., & Gran, B. (2010). Multiple sclerosis: Autoimmune associations in multiple sclerosis. Nature Reviews Neurology, 6, 591–592.
29. Critical views in gastroenterology & hepatology: Fecal microbiota transplantation: Where is it leading? (2014). Gastroenterology & Hepatology (NY), 10, 307–309.
30. Cryan, J. F., & Dinan, T. G. (2012). Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour. Nature Reviews Neuroscience, 13, 701–712.
31. Cui, G., Qin, X., Wu, L., Zhang, Y., Sheng, X., Yu, Q., Zang, Y. Q. (2011). Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation. The Journal of Clinical Investigation, 121, 658–670.
32. Dam, A. N., Berg, A. M., & Farraye, F. A. (2013). Environmental influences on the onset and clinical course of Crohn’s disease—Part 1: An overview of external risk factors. Gastroenterology & Hepatology (NY), 9, 711–717.
33. Das, S., & Das, D. K. (2007). Anti-inflammatory responses of resveratrol. Inflammation & Allergy – Drug Targets, 6, 168–173.
34. David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Turnbaugh, P. J. (2014). Diet rapidly and reproducibly alters the human gut microbiome. Nature, 505, 559–563.
35. De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Lionetti, P. (2010). Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proceedings of the National Academy of Sciences of the United States of America, 107, 14691–14696.
36. Desvergne, B., Michalik, L., & Wahli, W. (2006). Transcriptional regulation of metabolism. Physiological Reviews, 86, 465–514.
37. Desvergne, B., & Wahli, W. (1999). Peroxisome proliferator-activated receptors: Nuclear control of metabolism. Endocrine Reviews, 20, 649–688.
38. Dutta, R., & Trapp, B. D. (2014). Relapsing and progressive forms of multiple sclerosis: Insights from pathology. Current Opinion in Neurology, 27, 271–278.
39. Erridge, C., Attina, T., Spickett, C. M., & Webb, D. J. (2007). A high-fat meal induces low-grade endotoxemia: Evidence of a novel mechanism of postprandial inflammation. American Journal of Clinical Nutrition, 86, 1286–1292.
40. Farinotti, M., Simi, S., Di Pietrantonj, C., McDowell, N., Brait, L., Lupo, D., Filippini, G. (2007). Dietary interventions for multiple sclerosis. Cochrane Database of Systematic Reviews, 1, CD004192 pub2.
41. Farinotti, M., Vacchi, L., Simi, S., Di Pietrantonj, C., Brait, L., & Filippini, G. (2012). Dietary interventions for multiple sclerosis. Cochrane Database of Systematic Reviews, 12, CD004192. doi:10.1002/14651858.CD004192.pub3.
42. Farooqui, A. A., Horrocks, L. A., & Farooqui, T. (2007). Modulation of inflammation in brain: A matter of fat. Journal of Neurochemistry, 101, 577–599.
43. Fernandez, O., Alvarez-Cermeno, J. C., Arroyo-Gonzàlez, R., Brieva, L., Calles-Hernàndez, M. C., Casanova-Estruch, B., Montalban, X.; Post-ECTRIMS group. (2012). Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I). Revista de Neurologia, 54, 677–691.
44. Fernandez, O., Martin, R., Rovira, A., Llufriu, S., Vidal-Jordana, A., Fernandez-Sanchez, V. E., Montalban, X. (2014). Biomarkers in multiple sclerosis: An update for 2014. Revista de Neurologia, 58, 553–570.
45. Florindo, M. (2014). Inflammatory cytokines and physical activity in multiple sclerosis. ISRN Neurology, 151–572. doi: 10.1155/ 2014/151572.
46. Fragoso, Y. D., Stoney, P. N., & McCaffery, P. J. (2014). The evidence for a beneficial role of vitamin A in multiple sclerosis. CNS Drugs, 28, 291–299.
47. Friedman, M. (2007). Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas. Molecular Nutrition & Food Research, 51, 116–134.
48. Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmidbauer, M., Lassmann, H. (2009). The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain, 132, 1175–1189.
49. Gacias, M., & Casaccia, P. (2013). Promoting return of function in multiple sclerosis: An integrated approach. Multiple Sclerosis and Related Disorders, 2(4) doi: 10.1016/j.msard.2013.04.002.
50. Galland, G. (2010). Diet and inflammation (invited review). Nutrition in Clinical Practice, 25, 634–640.
51. Ghanim, H., Abuaysheh, S., Sia, C. L., Korzeniewski, K., Chaudhuri, A., Fernandez-Real, J. M., Dandona, P. (2009). Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells following a high-fat high-carbohydrate meal: Implications for insulin resistance. Diabetes Care, 32, 2281–2287.
52. Gilgun-Sherki, Y., Melamed, E., & Offen, D. (2004). The role of oxidative stress in the pathogenesis of multiple sclerosis: The need for effective antioxidant therapy. Journal of Neurology, 251, 261–268.
53. Gray, E., Ginty, M., Kemp, K., Scolding, N., & Wilkins, A. (2012). The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function. Journal of Neuroinflammation, 9, 63.
54. Gupta, S. C., Tyagi, A. K., Deshmukh-Taskar, P., Hinojosa, M., Prasad, S., & Aggarwal, B. B (2014). Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols. Archives of Biochemistry and Biophysics, 559, 91–99. doi: 10.1016/j.abb.2014.06.006.
55. Hadgkiss, E. J., Jelinek, G. A., Weiland, T. J., Pereira, N. G., Marck, C. H., & van der Meer D. M. (2014). The association of diet with quality of life, disability, and relapse rate in an international sample of people with multiple sclerosis. Nutritional Neurosciences, PMID: 24628020.
56. Harris, J. I., Hibbeln, J. R., Mackey, R. H., & Muldoon, M. F. (2004). Statin treatment alters serum n-3 and n-6 fatty acids in hypercholesterolemic patients. Prostaglandins, Leukotrienes and Essential Fatty Acids, 71, 263–269.
57. Hedström, A. K., Hillert, J., Olsson, T., & Alfredsson, L. (2014). Alcohol as a modifiable lifestyle factor affecting multiple sclerosis risk. JAMA Neurology, 71, 300–305.
58. Hedström, A. K., Olsson, T., & Alfredsson, L. (2012). High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Multiple Sclerosis, 18, 1334–1336.
59. Heneka, M. T., Landreth, G. E., & Hu¨ ll, M. (2007). Drug insight: Effects mediated by peroxisome proliferator-activated receptorgamma in CNS disorders. Nature Reviews Neurology, 3, 496–504.
60. Hong, S., & Lu, Y. (2013). Omega-3 fatty acid-derived resolvins and protectins in inflammation resolution and leukocyte functions: Targeting novel lipid mediator pathways in mitigation of acute kidney injury. Frontiers in Immunology, 4(12) doi: 10.3389/fimmu.2013.00013.
61. Hu, T., He, X. W., Jiang, J. G., & Xu, X. L. (2014). Hydroxytyrosol and its potential therapeutic effects. Journal of Agricultural and Food Chemistry, 62, 1449–1455.
62. Ingram, G., Loveless, S., Howell, O. W., Hakobyan, S., Dancey, B., Harris, C. L., Morgan, B. P. (2014). Complement activation in multiple sclerosis plaques: An immunohistochemical analysis. Acta Neuropathologica Communications, 2, 53.
63. Issazadeh-Navikas, S., Teimer, R., & Bockermann, R. (2012). Influence of dietary components on regulatory T cells. Molecular Medicine, 18, 95–110.
64. Jafari, N., & Hintzen, R. Q. (2011). The association between cigarette smoking and multiple sclerosis. Journal of the Neurological Sciences, 311, 78–85.
65. Joosen, A. M., Lecommandeur, E., Kuhnle, G. G., Aspinall, S. M., Kap, L., & Rodwell, S. A. (2010). Effect of dietary meat and fish on endogenous nitrosation, inflammation and genotoxicity of faecal water. Mutagenesis, 25, 243–247.
66. Katzen, M. (2013). The heart of the plate: Vegetarian recipes for a new generation Boston, NY: Houghton Mifflin Harcourt Publ. Co, pp. 1–456.
67. Kleinewietfeld, M., Manzel, A., Titze, J., Kvakan, H., Yosef, N., Linker, R. A., Hafler, D. A. (2013). Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature, 496, 518–522.
68. Kòsa, J. P., Horvàth, P., Wölfling, J., Kovàcs, D., Balla, B., Màtyus, P., Lakatos, P. (2013). CYP24A1 inhibition facilitates the anti-tumor effect of vitamin D3 on colorectal cancer cells. World Journal of Gastroenterology, 19, 2621–2628.
69. Krishnan, A. V., & Feldman, D. (2010). Molecular pathways mediating the anti-inflammatory effects of calcitriol: Implications for prostate cancer chemoprevention and treatment. Endocrine-Related Cancer, 17, R19–R38.
70. Krumbholz, M., Derfuss, T., Hohlfeld, R., & Meinl, E. (2012). B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nature Reviews Neurology, 8, 613–623.
71. Kutzelnigg, A., & Lassmann, H. (2014). Pathology of multiple sclerosis and related inflammatory demyelinating diseases. Handbook of Clinical Neurology, 122, 15–58.
72. Lassmann, H. (2013). Relapsing-remitting and primary progressive MS have the same cause(s)—The neuropathologist’s view. Multiple Sclerosis, 19, 266–267.
73. Latronico, T., Branà, M. T., Merra, E., Fasano, A., Di Bari, G., Casalino, E., Liuzzi, G. M. (2013). Impact of manganese neurotoxicity on MMP-9 production and superoxide dismutase activity in rat primary astrocytes. Effect of resveratrol and therapeutical implications for the treatment of CNS diseases. Toxicological Sciences, 135, 218–228.
74. Lee, S., & Kwak, H. B. (2014). Effects of interventions on adiponectin and adiponectin receptors. Journal of Exercise Rehabilitation, 10, 60–68.
75. Leong, EM, Semple, SJ, Angley, M, Siebert, W, Petkov, J, & McKinnon, RA (2009). Complementary and alternative medicines and dietary interventions in multiple sclerosis: What is being used in South Australia and why? Complementary Therapies in Medicine, 17, 216–223.
76. Liu, H., Ren, J., Chen, H., Huang, Y., Li, H., Zhang, Z., Wang, J. (2014). Resveratrol protects against cigarette smoke-induced oxidative damage and pulmonary inflammation. Journal of Biochemical and Molecular Toxicology, 28(10): 465–471.
77. Liuzzi, G. M., Latronico, T., Branà, M. T., Gramegna, P., Coniglio, M. G., Rossano, R., Riccio, P. (2011). Structure-dependent inhibition of gelatinases by dietary antioxidants in rat astrocytes and sera of multiple sclerosis patients. Neurochemical Research, 36, 518–527.
78. Liuzzi, G. M., Latronico, T., Fasano, A., Carlone, G., & Riccio, P. (2004). Interferon-beta inhibits the expression of metalloproteinases in rat glial cell cultures: Implications for multiple sclerosis pathogenesis and treatment. Multiple Sclerosis, 10, 290–297.
79. Liuzzi, G. M., Latronico, T., Rossano, R., Viggiani, S., Fasano, A., & Riccio, P. (2007). Inhibitory effect of polyunsaturated fatty acids on MMP-9 release from microglial cells-implications for complementary multiple sclerosis treatment. Neurochemical Research, 32(12): 2184–2193.
80. Liuzzi, G. M., Trojano, M., Fanelli, M., Avolio, C., Fasano, A., Livrea, P., Riccio, P. (2002). Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis. Implication for pathogenesis. Multiple Sclerosis, 8, 222–228.
81. Loleit, V., Biberacher, V., & Hemmer, B. (2014). Current and future therapies targeting the immune system in multiple sclerosis. Current Pharmaceutical Biotechnology, 15(3): 276–296.
82. Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K., & Knight, R. (2012). Diversity, stability and resilience of the human gut microbiota. Nature, 489, 220–230.
83. Lublin, F. D., Reingold, S. C., Cohen, J. A., Cutter, G. R., Sørensen, P. S., Thompson, A. J., Polman, C. H. (2014). Defining the clinical course of multiple sclerosis: The 2013 revisions. Neurology, 83, 278–286. 28.
84. Manouchehrinia, A., Tench, C. R., Maxted, J., Bibani, R. H., Britton, J., & Constantinescu, C. S. (2013). Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study. Brain, 136, 2298–2304.
85. Margioris, A. N. (2009). Fatty acids and postprandial inflammation. Current Opinion in Clinical Nutrition and Metabolic Care, 12, 129–137.
86. Massa, J., O’Reilly, E. J., Munger, K. L., & Ascherio, A. (2013). Caffeine and alcohol intakes have no association with risk of multiple sclerosis. Multiple Sclerosis, 19, 53–58.
87. Mastronardi, F. G., Min, W., Wang, H., Winer, S., Dosch, M., Boggs, J. M., Moscarello, M. A. (2004). Attenuation of experimental autoimmune encephalomyelitis and nonimmune demyelination by IFN-beta plus vitamin B12: Treatment to modify notch-1/sonic hedgehog balance. The Journal of Immunology, 172, 6418–6426.
88. Maynard, C. L., Elson, C. O., Hatton, R. D., & Weaver, C. T. (2012). Reciprocal interactions of the intestinal microbiota and immune system. Nature, 489, 231–241.
89. McFarland, H. F., & Martin, R. (2007). Multiple sclerosis: A complicated picture of autoimmunity. Nature Immunology, 8, 913–919.
90. McLeod, J. G., Hammond, S. R., & Kurtzke, J. F. (2011). Migration and multiple sclerosis in immigrants to Australia from United Kingdom and Ireland: A reassessment. I. Risk of MS by age at immigration. Journal of Neurology, 258, 1140–1149.
91. Mehta, L. R., Dworkin, R. H., & Schwid, S. R. (2009). Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis. Nature Clinical Practice Neurology, 5, 82–92.
92. Min, Y. D., Choi, C. H., Bark, H., Son, H. Y., Park, H. H., Lee, S., Kim, S. H. (2007). Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kappaB and p38 MAPK in HMC-1 human mast cell line. Inflammation Research, 56, 210–215.
93. Mitro, N., Mak, P. A., Vargas, L., Godio, C., Hampton, E., Molteni, V., Saez, E. (2007). The nuclear receptor LXR is a glucose sensor. Nature, 445, 219–223.
94. Montonen, J., Boeing, H., Fritsche, A., Schleicher, E., Joost, H. G., Schulze, M. B., Pischon, T. (2013). Consumption of red meat and whole-grain bread in relation to biomarkers of obesity, inflammation, glucose metabolism and oxidative stress. European Journal of Nutrition, 52, 337–345.
95. Moschen, A. R., Wieser, V., & Tilg, H. (2012). Dietary factors: Major regulators of the gut’s microbiota. Gut and Liver, 6, 411–416.
96. Munger, K. L. (2013). Childhood obesity is a risk factor for multiple sclerosis. Multiple Sclerosis, 19, 1800.
97. Narkar, V. A., Downes, M., Yu, R. T., Embler, E., Wang, Y. X., Banayo, E., Evans, R. M. (2008). AMPK and PPAR-delta agonists are exercise mimetics. Cell, 134, 405–415.
98. Nath, N., Khan, M., Paintlia, M. K., Hoda, M. N., & Giri, S. (2009). Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis. The Journal of Immunology, 182, 8005–8014.
99. Nelissen, K., Mulder, M., Smets, I., Timmermans, S., Smeets, K., Ameloot, M., Hendriks, J. J. (2012). Liver X receptors regulate cholesterol homeostasis in oligodendrocytes. Journal of Neuroscience Research, 90, 60–71.
100. Nordvik, I., Myhr, K. M., Nyland, H., & Bjerve, K. S. (2000). Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients. Acta Neurologica Scandinavica, 102, 143–149.
101. Okada, Y., Tsuzuki, Y., Ueda, T., Hozumi, H., Sato, S., Hokari, R., Miura, S. (2013). Trans fatty acids in diets act as a precipitating factor for gut inflammation? Journal of Gastroenterology and Hepatology, 28, 29–32.
102. Padler-Karavani, V., Yu, H., Cao, H., Chokhawala, H., Karp, F., Varki, N., Varki, A. (2008). Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: Potential implications for disease. Glycobiology, 18, 818–830.
103. Panda, S., Guarner, F., & Manichanh, C. (2014). Structure and functions of the gut microbiome. Endocrine, Metabolic & Immune Disorders – Drug Targets, PMID: 25022563.
104. Penberthy, W. T., & Tsunoda, I. (2009). The importance of NAD in multiple sclerosis. Current Pharmaceutical Design, 15, 64–99.
105. Pèrez, E., Bourguet, W., Gronemeyer, H., & de Lera, A. R. (2012). Modulation of RXR function through ligand design. Biochimica et Biophysica Acta, 1821, 57–69.
106. Petriz, B. A., Castro, A. P., Almeida, J. A., Gomes, C. P., Fernandes, G. R., Kruger, R. H., Franco, O. L. (2014). Exercise induction of gut microbiota modifications in obese, non-obese and hypertensive rats. BMC Genomics, 15, 511.
107. Piccio, L., Cantoni, C., Henderson, J. G., Hawiger, D., Ramsbottom, M., Mikesell, R., Cross, A. H. (2013). Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis. European Journal of Immunology, 43, 2089–2100.
108. Piccio, L., Stark, J. L., & Cross, A. H. (2008). Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis. Journal of Leukocyte Biology, 84, 940–948.
109. Pierrot-Deseilligny, C. (2009). Clinical implications of a possible role of vitamin D in multiple sclerosis. Journal of Neurology, 256, 1468–1479.
110. Polidoro, L., Properzi, G., Marampon, F., Gravina, G. L., Festuccia, C., Di Cesare, E., Ferri, C. (2013). Vitamin D protects human endothelial cells from H2O2 oxidant injury through the Mek/ Erk-Sirt1 axis activation. Journal of Cardiovascular Translational Research, 6, 221–231.
111. Prasad, S., Tyagi, A. K., & Aggarwal, B. B. (2014). Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: The golden pigment from golden spice. Cancer Research and Treatment, 46, 2–18.
112. Rao, A. V., & Rao, L. G. (2007). Carotenoids and human health. Pharmacological Research, 55, 207–216.
113. Reed, J. L., De Souza, M. J., & Williams, N. I. (2010). Effects of exercise combined with caloric restriction on inflammatory cytokines. Applied Physiology, Nutrition, and Metabolism, 35, 573–582.
114. Reichelt, K. L., & Jensen, D. (2004). IgA antibodies against gliadin and gluten in multiple sclerosis. Acta Neurologica Scandinavica, 110, 239–241.
115. Riccio, P. (2004). The proteins of the milk fat globule membrane in the balance. Trends in Food Science and Technology, 15, 458–461.
116. Riccio, P. (2011). The molecular basis of nutritional intervention in multiple sclerosis: A narrative review. Complementary Therapies in Medicine, 19, 228–237.
117. Riccio, P., & Rossano, R. (2013). The role of nutrition in multiple sclerosis: A story yet to be written. Revista Espan˜ola de Esclerosis Mu´ltiple, 5, 24–37.
118. Riccio, P., Rossano, R., & Liuzzi, G. M. (2011). May diet and dietary supplements improve the wellness of multiple sclerosis patients? A molecular approach. Autoimmune Disorders, 2010, 249842.
119. Rice, C. M., Sun, M., Kemp, K., Gray, E., Wilkins, A., & Scolding, N. J. (2012). Mitochondrial sirtuins—A new therapeutic target for repair and protection in multiple sclerosis. European Journal of Neuroscience, 35, 1887–1893.
120. Rossano, R., Larocca, M., Riviello, L., Coniglio, M. G., Vandooren, J., Liuzzi, G. M., Riccio, P. (2014). Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants. Journal of Cellular and Molecular Medicine, 18, 242–252.
121. Salinthone, S., Yadav, V., Bourdette, D. N., & Carr, D. W. (2008). Lipoic acid: A novel therapeutic approach for multiple sclerosis and other chronic inflammatory diseases of the CNS. Endocrine, Metabolic & Immune Disorders – Drug Targets, 8, 132–142.
122. Sato, F., Martinez, N. E., Shahid, M., Rose, J. W., Carlson, N. G., & Tsunoda, I. (2013). Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis. American Journal of Pathology, 183, 1390–1396.
123. Schmitz, G., & Ecker, J. (2008). The opposing effects of n-3 and n-6 fatty acids. Progress in Lipid Research, 47, 147–155.
124. Schnegg, C. I., & Robbins, M. E. (2011). Neuroprotective mechanisms of PPARd: Modulation of oxidative stress and inflammatory processes. PPAR Research, 2011, 373560.
125. Schuster, I. (2011). Cytochromes P450 are essential players in the vitamin D signaling system. Biochimica et Biophysica Acta, 1814, 186–199.
126. Schwarz, S., Knorr, C., Geiger, H., & Flachenecker, P. (2008). Complementary and alternative medicine for multiple sclerosis. Multiple Sclerosis, 14, 1113–1119.
127. Schwingshackl, L., & Hoffmann, G. (2014). Mediterranean dietary pattern, inflammation and endothelial function: A systematic review and meta-analysis of intervention trials. Nutrition, Metabolism, and Cardiovascular Diseases, 24, 929–939.
128. Serhan, C. N., & Chiang, N. (2013). Resolution phase lipid mediators of inflammation: Agonists of resolution. Current Opinion in Pharmacology, 13, 632–640.
129. Seyfried, T. N., Flores, R. E., Poff, A. M., & D’Agostino, D. P. (2014). Cancer as a metabolic disease: Implications for novel therapeutics. Carcinogenesis, 235, 515–527.
130. Shakibaei, M., Harikumar, K. B., & Aggarwal, B. B. (2009). Resveratrol addiction: To die or not to die. Molecular Nutrition & Food Research, 53, 115–128.
131. Shinto, L., Marracci, G., Baldauf-Wagner, S., Strehlow, A., Yadav, V., Stuber, L., Bourdette, D. (2009). Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis. Prostaglandins Leukotrienes and Essential Fatty Acids, 80, 131–136.
132. Sie, C., Korn, T., & Mitsdoerffer, M. (2014). Th17 cells in central nervous system autoimmunity. Experimental Neurology, 262PA, 18–27. doi: 10.1016/j.expneurol.2014.03.009
133. Smits, L. P., Bouter, K. E., de Vos, W. M., Borody, T. J., & Nieuwdorp, M. (2013). Therapeutic potential of fecal microbiota transplantation. Gastroenterology, 145, 946–953.
134. Smolders, J., Damoiseaux, J., Menheere, P., & Hupperts, R. (2008). Vitamin D as an immune modulator in multiple sclerosis, a review. Journal of Neuroimmunology, 194, 7–17.
135. Steinberg, G. R., & Kemp, B. E. (2009). AMPK in health and disease. Physiological Reviews, 89, 1025–1078.
136. Stenson, W. F. (2014). The universe of arachidonic acid metabolites in inflammatory bowel disease: Can we tell the good from the bad? Current Opinion in Gastroenterology, 30, 347–351.
137. Sternberg, Z., Chadha, K., Lieberman, A., Hojnacki, D., Drake, A., Zamboni, P., Munschauer, F. (2008). Quercetin and interferon- beta modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patients. Journal of Neuroimmunology, 205, 142–147.
138. Su, K. G., Banker, G., Bourdette, D., & Forte, M. (2009). Axonal degeneration in multiple sclerosis: The mitochondrial hypothesis. Current Neurology and Neuroscience Reports, 9, 411–417.
139. Swank, R. L., & Goodwin, J. W. (2003). Review of MS patient survival on a Swank low saturated fat diet. Nutrition, 19, 161–165.
140. Swanson, R. M., Gavin, M. A., Escobar, S. S., Rottman, J. B., Lipsky, B. P., Dube, S., Viney, J. L. (2013). Butyrophilinlike 2 modulates B7 costimulation to induce Foxp3 expression and regulatory T cell development in mature T cells. The Journal of Immunology, 190, 2027–2035.
141. Tilg, H., Moschen, A. R., & Kaser, A. (2009). Obesity and the microbiota. Gastroenterology, 136, 1476–1483.
142. Tremaroli, V., & Bäckhed, F. (2012). Functional interactions between the gut microbiota and host metabolism. Nature, 489, 242–249.
143. Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., Renauld, J. C., Stockinger, B. (2008). The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature, 453, 106–109.
144. Venkatesan, A., & Johnson, R. T. (2014). Infections and multiple sclerosis. Handbook of Clinical Neurology, 122, 151–171.
145. Visioli, F., De La Lastra, C. A., Andres-Lacueva, C., Aviram, M., Calhau, C., Cassano, A., Edeas, M. (2011). Polyphenols and human health: A prospectus. Critical Reviews in Food Science and Nutrition, 51, 524–546.
146. Wang, Y., & Kasper, L. H. (2014). The role of microbiome in central nervous system disorders. Brain, Behavior, and Immunity, 38, 1–12. doi: 10.1016/j.bbi.2013.12.015.
147. Wang, S., Moustaid-Moussa, N., Chen, L., Mo, H., Shastri, A., Su, R., Shen, C. L. (2014). Novel insights of dietary polyphenols and obesity. The Journal of Nutritional Biochemistry, 25(1): 1–18. doi: 10.1016/j.jnutbio.2013.09.001.
148. Weiland, T. J., Hadgkiss, E. J., Jelinek, G. A., Pereira, N. G., Marck, C. H., & van der Meer, D. M. (2014). The association of alcohol consumption and smoking with quality of life, disability and disease activity in an international sample of people with multiple sclerosis. Journal of the Neurological Sciences, 336, 211–219.
149. Weinstock-Guttman, B., Baier, M., Park, Y., Feichter, J., Lee- Kwen, P., Gallagher, E., Rudick, R. (2005). Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients. Prostaglandins Leukotrienes and Essential Fatty Acids, 73, 397–404.
150. World Health Organization & Multiple Sclerosis International Federation Atlas. Multiple sclerosis resources in the world 2008. Geneva: World Health Organization. Retrieved from http://www.who.int/mental_health/neurology/Atlas_MS_WEB.pdf. World Health Organization Globalrecommendations on physical activity for health. Geneva, Switzerland: WHO Library Cataloguing-in-Publication Data, 2010.
151. Williams, R., Buchheit, C. L., Berman, N. E., & LeVine, S. M. (2012). Pathogenic implications of iron accumulation in multiple sclerosis. Journal of Neurochemistry, 120, 7–25.
152. Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y. Y., Keilbaugh, S. A., Lewis, J. D. (2011). Linking long-term dietary patterns with gut microbial enterotypes. Science, 334, 105–108.
153. Wu, C., Yosef, N., Thalhamer, T., Zhu, C., Xiao, S., Kishi, Y., Kuchroo, V. K. (2013). Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature, 496, 513–517.
154. Xu, X., So, J. S., Park, J. G., & Lee, A. H. (2013). Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP. Seminars in Liver Disease, 33, 301–311.
155. Xu, Z. Z., Zhang, L., Liu, T., Park, J. Y., Berta, T., Yang, R., Ji, R. R. (2010). Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nature Medicine, 16, 592–597.
156. Yan, J., & Greer, J. M. (2008). NF-kappa B, a potential therapeutic target for the treatment of multiple sclerosis. CNS & Neurological Disorders – Drug Targets, 7, 536–557.
157. Yanai, R., Mulki, L., Hasegawa, E., Takeuchi, K., Sweigard, H., Suzuki, J., Connor, K. M. (2014). Cytochrome P450-generated metabolites derived from u`-3 fatty acids attenuate neovascularization. Proceedings of the National Academy of Sciences of the United States of America, 111, 9603–9608.
158. Yasari, S., Wang, D., Prud’homme, D., Jankowski, M., Gutkowska, J., & Lavoie, J. M. (2009). Exercise training decreases plasma leptin levels and the expression of hepatic leptin receptor-a, -b, and, -" in rats. Molecular and Cellular Biochemistry, 324, 13–20.
159. Yin, K., & Agrawal, D. K. (2014). Vitamin D and inflammatory diseases. Journal of Inflammation Research, 7, 69–87.
160. Yokote, H., Miyake, S., Croxford, J. L., Oki, S., Mizusawa, H., & Yamamura, T. (2008). NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora. American Journal of Pathology, 173, 1714–1723.
161. You, M., Liang, X., Ajmo, J. M., & Ness, G. C. (2008). Involvement of mammalian sirtuin 1 in the action of ethanol in the liver. American Journal of Physiology – Gastrointestinal and Liver Physiology, 294, G892–G898.
162. Zanella, S. G., & Roberti di Sarsina, P. (2013). Personalization of multiple sclerosis treatments: Using the chelation therapy approach. Explore (NY), 9, 244–248.
163. Zhang, S. M., Hernàn, M. A., Olek, M. J., Spiegelman, D., Willett, W. C., & Ascherio, A. (2001). Intakes of carotenoids, vitamin C, and vitamin E and MS risk among two large cohorts of women. Neurology, 57, 75–80.
164. Zhang, F., Wang, S., Gan, L., Vosler, P. S., Gao, Y., Zigmond, M. J., Chen, J. (2011). Protective effects and mechanisms of sirtuins in the nervous system. Progress in Neurobiology, 95, 373–395.
165. Zhang-Gandhi, C. X., & Drew, P. D. (2007). Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes. Journal of Neuroimmunology, 183, 50–59.
166. Zhao, S., Li, R., Li, Y., Chen, W., Zhang, Y., & Chen, G. (2012). Roles of vitamin A status and retinoids in glucose and fatty acid metabolism. Biochemistry and Cell Biology, 90, 142–152.
167. Zhou, X., Yuan, L., Zhao, X., Hou, C., Ma, W., Yu, H., Xiao, R. (2014). Genistein antagonizes inflammatory damage induced by b-amyloid peptide in microglia through TLR4 and NF-kB. Nutrition, 30, 90–95.